Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Increases Roseburia - : Poly[β-D-xylopyranose(1->4)] {Xylan} |
📓
Contribution of acetate to butyrate formation by human faecal bacteria. The British journal of nutrition (Br J Nutr ) Vol: 91 Issue 6 Pages: 915-23 Pub: 2004 Jun Epub: Authors Duncan SH , Holtrop G , Lobley GE , Calder AG , Stewart CS , Flint HJ , Publication Publication |
| Increases Roseburia - : Poly[β-D-xylopyranose(1->4)] {Xylan} |
📓
The role of short-chain fatty acids in microbiota-gut-brain communication. Nature reviews. Gastroenterology & hepatology (Nat Rev Gastroenterol Hepatol ) Vol: 16 Issue 8 Pages: 461-478 Pub: 2019 Aug Epub: Authors Dalile B , Van Oudenhove L , Vervliet B , Verbeke K , Publication Publication |
| Increases Roseburia - : Poly[β-D-xylopyranose(1->4)] {Xylan} |
📓
Bamboo shavings derived O-acetylated xylan alleviates loperamide-induced constipation in mice. Carbohydrate polymers (Carbohydr Polym ) Vol: 276 Issue Pages: 118761 Pub: 2022 Jan 15 Epub: 2021 Oct 15 Authors Huang J , Lin B , Zhang Y , Xie Z , Zheng Y , Wang Q , Xiao H , Publication |
| Decreases Roseburia - : Poly[β-D-xylopyranose(1->4)] {Xylan} |
👶
The effect of cocultivation with hydrogen-consuming bacteria on xylanolysis byRuminococcus flavefaciens Current Microbiology (Current Microbiology ) Vol: 29 Issue 3 Pages: 113-138 Pub: Sep 1994 Epub: Authors A. G. Williams , |
| 0 π | π’ 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]